Evidence map›Paper›PMID 31477753›Full record

ArticleScientific reports2019

Six-fold director field configuration in amyloid nematic and cholesteric phases.

Massimo Bagnani, Paride Azzari, Salvatore Assenza, Raffaele Mezzenga

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. LLPSSoft matter · 2023
    Review
  5. Amyloid Fibrils of Stefin B Show Anisotropic Properties.International journal of molecular sciences · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Metal ions confinement defines the architecture of G-quartet, G-quadruplex fibrils and their assembly into nematic tactoids.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Massimo BagnaniETH Zurich, Department of Health Sciences and Technology, Schmelzbergstrasse 9, LFO E23, Zurich, 8092, Switzerland.ORCID http://orcid.org/0000-0002-1326-1600
Paride AzzariETH Zurich, Department of Health Sciences and Technology, Schmelzbergstrasse 9, LFO E23, Zurich, 8092, Switzerland.ORCID http://orcid.org/0000-0001-5400-1576
Salvatore AssenzaETH Zurich, Department of Health Sciences and Technology, Schmelzbergstrasse 9, LFO E23, Zurich, 8092, Switzerland.ORCID http://orcid.org/0000-0001-9983-8927
Raffaele MezzengaETH Zurich, Department of Health Sciences and Technology, Schmelzbergstrasse 9, LFO E23, Zurich, 8092, Switzerland. raffaele.mezzenga@hest.ethz.ch.ORCID http://orcid.org/0000-0002-5739-2610

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chiral liquid crystals, or cholesteric phases, have been widely studied in the last decades, leading to fundamental advances and a multitude of applications and technologies. In general, the rich phenomenology of these systems depends directly on the molecular traits and conditions of the system, imposing precise symmetry to the resulting nematic field. By selecting amyloid fibrils as model filamentous chiral colloids, we report an unprecedented breadth of liquid crystalline morphologies, where up to six distinct configurations of the nematic field are observed under identical conditions. Amyloid-rich droplets show homogeneous, bipolar, radial, uniaxial chiral and radial chiral nematic fields, with additional parabolic focal conics in bulk. Variational and scaling theories allow rationalizing the experimental evidence as a subtle interplay between surface and bulk energies. Our experimental and theoretical findings deepen the understanding of chiral liquid crystals under confinement, opening to a more comprehensive exploitation of these systems in related functional materials.

Identifiers

PMID31477753
PMCPMC6718687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.